Larvol Delta - Marker-Therapeutics-Awarded-95-Million-Grant-from-the-Cancer-Prevention-amp-Research-Institute-of-Texas-CPRIT-to-Support-the-Investigation-of-MT601-in-Patients-with-Pancreatic-Cancer

neldaleucel (MT-601) - Marker Therap

https://www.globenewswire.com/news-release/2024/12/17/2998125/0/en/Marker-Therapeutics-Awarded-9-5-Million-Grant-from-the-Cancer-Prevention-Research-Institute-of-Texas-CPRIT-to-Support-the-Investigation-of-MT-601-in-Patients-with-Pancreatic-Cancer.html

Dec 17, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next